Sherbrooke Park Advisers LLC Amneal Pharmaceuticals, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 66,567 shares of AMRX stock, worth $558,497. This represents 0.13% of its overall portfolio holdings.
Number of Shares
66,567Holding current value
$558,497% of portfolio
0.13%Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$183 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$123 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...